Lineage Cell Therapeutics Inc. — Director's Dealing 2012

Nov 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-11-15

Reporting Person: KINGSLEY ALFRED D (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-15	Common Shares, no par value	S	344828	$2.90	Disposed	7167566	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	1968505	Indirect
Common Shares, no par value	490373	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Puchase Common Shares	$4.60	2017-06-30	Common Shares (50000)	50000	Direct
Option to Puchase Common Shares	$5.13	2016-06-30	Common Shares (50000)	50000	Direct
Option to Puchase Common Shares	$5.45	2015-08-09	Common Shares (50000)	50000	Direct
Option to Puchase Common Shares	$2.30	2014-07-01	Common Shares (50000)	50000	Direct

Footnotes

F1: On November 15, 2012, Mr. Kingsley sold 344,828 BioTime common shares in a private transaction.

F2: Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.

F3: 12,500 options became exercisable on September 30, 2012 and the remaining 37,500 options will become exercisable in 3 equal quarterly installments based upon continued service on the board of directors.

F4: 12,500 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.

F5: 12,500 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.

F6: 12,500 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.